HLN
Haleon plc · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth -5.9% ·
share flow -4.5% ·
net new positions -12.5%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 156.92K | $1.42M | n/a | n/a |
| Q2 2026 | 105 | +5 | 532.53M | $4.91B | +8 | −2 |
| Q1 2026 | 100 | +1 | 506.60M | $5.01B | +6 | −6 |
| Q4 2025 | 99 | -2 | 494.67M | $4.94B | +1 | −2 |
| Q3 2025 | 16 | -1 | 341.18M | $3.06B | +1 | −3 |
| Q2 2025 | 15 | 0 | 306.18M | $3.18B | +2 | −2 |
| Q1 2025 | 13 | 0 | 210.33M | $2.16B | n/a | n/a |
| Q4 2024 | 13 | +1 | 208.23M | $1.99B | +2 | −1 |
| Q3 2024 | 11 | 0 | 206.41M | $2.18B | +2 | −2 |
| Q2 2024 | 11 | n/a | 210.64M | $1.74B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 154.38M | -0.7% | $1.38B | 0.7% | ▼ Trim | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 104.00M | -6.9% | $932.90M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 3 | JPMorgan Chase ✦ | 23.97M | n/a | $215.01M | 0.0% | n/c | 1 | SEC ↗ ×26 |
| 4 | Morgan Stanley ✦ | 18.53M | n/a | $166.24M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 5 | Wellington Management ✦ | 15.68M | -6.0% | $140.65M | 0.0% | ▼ Trim | 6 | SEC ↗ ×6 |
| 6 | Goldman Sachs Group ✦ | 8.85M | n/a | $79.40M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 7 | BlackRock ✦ (passive) | 6.25M | -2.7% | $56.06M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 8 | Citadel Advisors ✦ | 3.72M | -18.6% | $33.37M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Point72 Asset Management ✦ | 2.36M | +2542.4% | $21.19M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 1.43M | -81.6% | $12.87M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Millennium Management ✦ | 971.81K | -54.8% | $8.72M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 331.62K | -6.3% | $2.97M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (passive) | 292.85K | -6.4% | $2.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 181.80K | New | $1.63M | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 138.75K | +8.3% | $1.24M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 16 | Tweedy, Browne ✦ | 76.67K | -0.2% | $687,712 | 0.1% | ▼ Trim | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $1.63M | 0.0% |
Exited
| Norges Bank | $2.85M | was 0.0% |
| Marshall Wace | $631,989 | was 0.0% |
| Two Sigma Investments | $371,630 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 618 holders, 559.47M shares, $5.40B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.